ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,114.63
-0.01%
Dow Jones
44,546.08
-0.37%
US Dollar vs MXN
20.27921
-0.13%
Brent Oil
74.91
0.91%
Bitcoin
95,495.01
-0.66%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Passage Bio Inc (PASG)

  7. Passage Bio Inc (PASG) Noticias

Passage Bio Inc

Passage Bio Inc (PASG)

NASDAQ
0.56
0.0368
(7.03%)
Cerrado 17 Febrero 3:00PM
Delayed by 15 minutes
0.5621
0.0021
(0.37%)
Fuera de horario: 6:59PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

PASG Noticias

Solo noticias oficiales

Form 8-K - Current report
Edgar (US Regulatory)
16 Septiembre 2024
PASG (7.03%)

Form 8-K - Current report
Edgar (US Regulatory)
10 Septiembre 2024
PASG (7.03%)

Form 8-K - Current report
Edgar (US Regulatory)
06 Septiembre 2024
PASG (7.03%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
08 Agosto 2024
PASG (7.03%)

Form 8-K - Current report
Edgar (US Regulatory)
08 Agosto 2024
PASG (7.03%)

Form 8-K - Current report
Edgar (US Regulatory)
02 Agosto 2024
PASG (7.03%)

Form 8-K - Current report
Edgar (US Regulatory)
01 Agosto 2024
PASG (7.03%)

PASG Discussion

Ver más
glenn1919 glenn1919 2 meses hace
pasg.....................out
👍️0
tw0122 tw0122 2 meses hace
373,645
👍️0
tw0122 tw0122 2 meses hace
Insider acquired shares 12-31
👍️0
tw0122 tw0122 2 meses hace
Pass some gas PASG .67
👍️0
PonkenPlonken PonkenPlonken 2 meses hace
make or break
👍️0
PonkenPlonken PonkenPlonken 2 meses hace
Wedbush pump losing steam
the dilemma is the readouts are right around the corner
👍️0
Stumblebum Stumblebum 3 meses hace
Next week should be interesting….will Pasg hold its gains or tank…was it a pump and dump day…..15 million share volume today …..massive increase …..hmmmmm
👍️0
PonkenPlonken PonkenPlonken 3 meses hace
EVERYTHING the analyst said today was well known.
Direct CNS delivery... AAV gene therapy pioneer thinks AAV gene therapy will work in FTD too.... First one of its kind in FTD.... Then in recent months we got about a million validations of that ---------- No one bit this? They didnt believe him? Because he left again for head of gene therapy at PENNs and then went on to found 2 new companies instead of linger around at PASG at 60 something years?
No one believed he gave the steering wheel to Mr Chou because Wilson thought Chou could finish the job?
👍️0
PonkenPlonken PonkenPlonken 3 meses hace
Analyst says most basic stuff and they go crazy?
👍️0
PonkenPlonken PonkenPlonken 3 meses hace
will it keep going?
👍️0
PonkenPlonken PonkenPlonken 6 meses hace
big pop coming. Science hated for no reason. Founder is gene therapy authority. AAV tech works.
👍️0
Monksdream Monksdream 6 meses hace
PASG 10Q due AUGUST5
👍️0
PonkenPlonken PonkenPlonken 7 meses hace
See the first rally on this after the big bar on the first data release. They saw something and took a seat. A lot of shares were bought. Thats because the platform works and will -- veeery surprisingly -- produce great data.
👍️0
PonkenPlonken PonkenPlonken 7 meses hace
this is not a daytrade. I am invested here, waiting for the crowd/data.
I think a deal is coming on data release.... its a neglected approach. Founder is a genius and gene therapy authority, popularized AAVs. All the recent bio winners use them.
Happy trading
👍️0
Awl416 Awl416 7 meses hace
Ahem..
👍️0
PonkenPlonken PonkenPlonken 7 meses hace
Going to explode on the next readout

Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
Agency feedback from Type C meeting process supports the company's proposed clinical development plans to expand the upliFT-D trial to assess PBFT02 in FTD patients with C9orf72 gene mutations


👍️0
Monksdream Monksdream 7 meses hace
There are close to 1,000 listed med tech companies
Only so many can garner serious institutional interest
👍️0
PonkenPlonken PonkenPlonken 7 meses hace
I wonder... when will people realize that the AAV stuff is great... CADL, SLDB, PASG

The founder certainly thinks so... and he is the authority on the topic:
"Dr. James M. Wilson serves as the Director of the Gene Therapy Program (GTP) at Penn's Perelman School of Medicine."

"The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy."
👍️0
Monksdream Monksdream 9 meses hace
PASG under $2
👍️0
Monksdream Monksdream 9 meses hace
PASG under $2
👍️0
Sirpeter Sirpeter 11 meses hace
Running... boom!!!
👍️0
Monksdream Monksdream 11 meses hace
PASG under $2
👍️0
glenn1919 glenn1919 11 meses hace
PASG..........................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 12 meses hace
PASG new 52 week high
👍️0
TrendTrade2016 TrendTrade2016 12 meses hace
PASG setting up nicely. Another beautiful call by the only true chartist around
👍️0
Sirpeter Sirpeter 12 meses hace
Yup yup yup...
👍️0
TrendTrade2016 TrendTrade2016 12 meses hace
PASG...NEXT CRDL
👍️0
glenn1919 glenn1919 12 meses hace
PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 12 meses hace
PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 12 meses hace
PASG under $2
👍️0
turning stone turning stone 1 año hace
As a new investor in PASG, I am looking forward to another high roller in the next number of years. I bought ARNA years ago at 1.90 and rode it out to $99/share when they were bought out by Phizer Pharm. I would like to have my 5 grandkids share the spoils on this one. With a multi-pipe line, a couple should make it to the end of the line with FDA approval. At the number of shares I purchased multiple times I can afford to run for the hills if a sudden disaster should hit this one. This company is 21 miles from my home and I will stop by shortly and have a sit down with their home-based PR. person. Good luck to all. You may also want to look at BLRX {BIO-Line Inc }










👍️0
Walter4 Walter4 1 año hace
Data readout should be incoming shortly
👍️ 1
Monksdream Monksdream 2 años hace
PASG new 52 week low
👍️0
catinhat catinhat 3 años hace
So...anybody out there? Thoughts on upcoming abstract, etc?

Recent long.
👍️0
dealerschool2006 dealerschool2006 4 años hace
PASG down from panic selling due to the pricing of its underwritten public offering of 7,000,000 shares of its common stock at a public offering price of $22.00 per share.
👍️0

Su Consulta Reciente

NASDAQ
PASG
Passage Bio
DGFX
ATMUSDT
Atletico de Madrid
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios